Incyte calls time on selling gene data
US company Incyte Genomics is closing down its Palo Alto-based gene information division, saying that the availability of free genetic databases on the Internet has scuppered the unit's business.
US company Incyte Genomics is closing down its Palo Alto-based gene information division, saying that the availability of free genetic databases on the Internet has scuppered the unit's business.
Pharmaceutical, chemical and coatings company Akzo Nobel reported a 9 per cent slide in net income in 2003 but said the result was better than expected given the difficult operating environment last year.
Hyderabad, India-based Dr Reddy's Laboratories has reported revenues of 5.1 billion rupees (€89m) in the third quarter of fiscal 2004, up 18 per cent and ahead of analysts' forecasts.
Agilent Technologies whole genome microarray - which packs every human gene onto a single 1" x 3" slide, is now commercially available.
Scientists at Switzerland's Roche have developed a small molecule that interferes with the binding of p53 - a protein that blocks the development of cancer - to its natural inhibitor. The discovery could open the door to novel, orally available drugs.
A cell culture vessel designed by Taiwanese company CESCO Bioengineering can produce the same amount of cells in a single 500ml bottle as would be made in 20 or more conventional roller bottles, according to the company which is introducing the device...
The widely used food ingredient inulin could be a more effective alternative to established excipients in stabilising protein-based medicines and improving their shelf life, according to researchers at the University of Groningen in the Netherlands.
AstraZeneca has launched new production lines at its production facility in Dunkerque in northern France, following a 24 per cent growth in its respiratory sales in 2003. The new lines will produce aerosol-delivered medicines for the treatment of asthma.